| Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors D Balan, O Martha, CB Chibelean, S Tataru, S Voidezan, A Sin, VD Matei, ... Medicine 97 (16), e0522, 2018 | 17 | 2018 |
| Easily available blood test neutrophil-to-lymphocyte ratio predicts progression in high-risk non-muscle invasive bladder cancer O Martha, D Porav-Hodade, D Bălan, OS Tătaru, A Sin, CB Chibelean, ... Revista Romana de Medicina de Laborator 25 (2), 181-189, 2017 | 15 | 2017 |
| Inflammatory markers and thromboembolic risk in patients with non-muscle-invasive bladder cancer D Balan, MD Vartolomei, A Magdás, N Balan-Bernstein, ST Voidăzan, ... Journal of Clinical Medicine 10 (22), 5270, 2021 | 6 | 2021 |
| The role of neutrophil to lymphocyte ratio in patients with pTa non-muscle invasive bladder cancer O Mártha, D Balan, D Porav-Hodade, E Drágus, MD Vartolomei, ... Revista Romana de Medicina de Laborator 28 (1), 29-38, 2020 | 6 | 2020 |
| Decrease in prostate cancer detection during COVID-19 pandemic D Porav-Hodade, D Balan, R Gherasim, OA Vida, C Todea-Moga, ... | 3 | 2021 |
| Fascin is secreted in male's serum: results of a pilot study D Porav-Hodade, O Martha, D Balan, S Tataru, A Hutanu, A Sin, ... Future Science OA 4 (3), FSO273, 2018 | 3 | 2018 |
| Metastatic prostate cancer with highest reported PSA level VMD Martha Orsolya, Tilinca Mariana , Tataru Octavian Sabin, Chiujdea Sever ... Acta Medica Marisiensis 62 (3), 2016 | 3* | 2016 |
| Urological practice during COVID-19 pandemic in Târgu Mureș O Amota, EA Frunda, V Ghirca, O Vida, C Todea, D Porav-Hodade, ... Romanian Journal of Urology 19 (1), 19-22, 2020 | 1 | 2020 |
| Abobotulinumtoxin A in idiopathic hyperactive bladder-ethical issues CB Chibelean, IA Nechifor-Boilă, RC Petca, D Balan, O Martha, A Petca, ... Rom J Leg Med 27, 213-216, 2019 | 1 | 2019 |
| Long-term Overall Survival of Patients with T1 Bladder Cancer following BCG Instillation. OS Tataru, D Porav-Hodade, O Martha, D Balan, MD Vartolomei, ... Romanian Journal of Urology 17 (1), 2018 | 1 | 2018 |
| Long term follow-up after TUR-B for NMIBC. An external validation of EORTC risk tables MD Vartolomei, D Balan, AS Stefan, M Tilinca, S Voidezan, CB Chibelean, ... European Urology Supplements 6 (14), e1325, 2015 | 1 | 2015 |
| Validation of the importance of neutrophil-to-lymphocyte ratio in non-muscle invasive bladder cancer PH Daniel, B Daniel, R Tibor, BB Noemi, VA Oliver, M Orsolya | | 2022 |
| Original Validation of the importance of neutrophil-to-lymphocyte ratio in non-muscle invasive bladder cancer PH Daniel, B Daniel, R Tibor, BB Noemi, VA Oliver, M Orsolya JOURNAL OF MENS HEALTH 18 (2), 2022 | | 2022 |
| Validation of the importance of neutrophil-to-lymphocyte ratio in non-muscle invasive bladder cancer MO Porav-Hodade Daniel, Balan Daniel, Reman Tibor, Balan-Bernstein Noemi ... Journal of Men's Health, 2021 | | 2021 |
| A Ta nem izom-invazív hólyagdaganatok korszerű kezelése B Daniel | | 2021 |
| PM. 5.5. Tumoră testiculară de tip mixt cu valori crescute ale beta-hCG-prezentare de caz E Drágus, D Balan, O Mártha Romanian Journal of Urology 20 (2), 65-65, 2021 | | 2021 |
| PM. 1.2. Evaluarea riscului trombembolic la pacienții cu tumoră vezicală non-muscular invazivă D Balan, A Magdas, N Balan-Bernstein, M Orsolya Romanian Journal of Urology 20 (2), 4-4, 2021 | | 2021 |
| PM. 4.5. Rolul Indicelui de Contractilitate Vezicală ca parametru urodinamic în diagnosticul detrusorului hipocontractil V Ghirca, C Todea, D Porav-Hodade, C Chibelean, D Balan, O Vida, ... Romanian Journal of Urology 20 (2), 51-51, 2021 | | 2021 |
| PM. 3.9. Sindromul Zinner–prezentare de caz C Todea-Moga, V Ghirca, D Porav-Hodade, D Balan, S Chiujdea, ... Romanian Journal of Urology 20 (2), 46-46, 2021 | | 2021 |
| Review of Smoking Cessation and Bladder Cancer N Balan-Bernstein, D Balan, C Mărginean, O Mártha Romanian Journal of Urology 20 (1), 5-7, 2021 | | 2021 |
Martha Orsolya K. I.Profesor Universitar, UMFST GE Palade Tg. MureșVerified email at umfst.ro
